1. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA). Issue 17 (10th June 2022) Authors: Ho, Alan L.; Dedecjus, Marek; Wirth, Lori J.; Tuttle, R. Michael; Inabnet, William B.; Tennvall, Jan; Vaisman, Fernanda; Bastholt, Lars; Gianoukakis, Andrew G.; Rodien, Patrice; Paschke, Ralf; Elisei, Rossella; Viola, David; So, Karen; Carroll, Danielle; Hovey, Tina; Thakre, Bhavana; Fagin, James A. Journal: Journal of clinical oncology Issue: Volume 40:Issue 17(2022) Page Start: 1870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗